These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16353603)

  • 1. A randomized double-blind crossover study of the antiobesity effects of etiocholanedione.
    Zumoff B; Strain GW; Heymsfield SB; Lichtman S
    Obes Res; 1994 Jan; 2(1):13-8. PubMed ID: 16353603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
    Heymsfield SB; Allison DB; Vasselli JR; Pietrobelli A; Greenfield D; Nunez C
    JAMA; 1998 Nov; 280(18):1596-600. PubMed ID: 9820262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Standardized
    Han HS; Chung KS; Shin YK; Yu JS; Kang SH; Lee SH; Lee KT
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.
    Finer N; James WP; Kopelman PG; Lean ME; Williams G
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):306-13. PubMed ID: 10757623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
    Shirai K; Fujita T; Tanaka M; Fujii Y; Shimomasuda M; Sakai S; Samukawa Y
    Adv Ther; 2019 Jan; 36(1):86-100. PubMed ID: 30535651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
    Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
    Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial.
    Park SJ; Sharma A; Bae MH; Sung HC; Kim NK; Sung E; Lee HJ
    J Med Food; 2020 Mar; 23(3):335-342. PubMed ID: 32130058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide has a pronounced effect on energy intake but not energy expenditure in non-diabetic subjects with obesity: A randomized, double-blind, placebo-controlled trial.
    Basolo A; Burkholder J; Osgood K; Graham A; Bundrick S; Frankl J; Piaggi P; Thearle MS; Krakoff J
    Metabolism; 2018 Aug; 85():116-125. PubMed ID: 29596853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.
    Aronne L; Fujioka K; Aroda V; Chen K; Halseth A; Kesty NC; Burns C; Lush CW; Weyer C
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2977-83. PubMed ID: 17504894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiobesity effect of Gynostemma pentaphyllum extract (actiponin): a randomized, double-blind, placebo-controlled trial.
    Park SH; Huh TL; Kim SY; Oh MR; Tirupathi Pichiah PB; Chae SW; Cha YS
    Obesity (Silver Spring); 2014 Jan; 22(1):63-71. PubMed ID: 23804546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.
    Grube B; Chong PW; Lau KZ; Orzechowski HD
    Obesity (Silver Spring); 2013 Jan; 21(1):58-64. PubMed ID: 23505169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study.
    Chong PW; Beah ZM; Grube B; Riede L
    Phytother Res; 2014 Oct; 28(10):1520-6. PubMed ID: 24797657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A; Frandsen E; Kondrup J
    Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
    Lustig RH; Greenway F; Velasquez-Mieyer P; Heimburger D; Schumacher D; Smith D; Smith W; Soler N; Warsi G; Berg W; Maloney J; Benedetto J; Zhu W; Hohneker J
    Int J Obes (Lond); 2006 Feb; 30(2):331-41. PubMed ID: 16158082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
    Ettinger MP; Littlejohn TW; Schwartz SL; Weiss SR; McIlwain HH; Heymsfield SB; Bray GA; Roberts WG; Heyman ER; Stambler N; Heshka S; Vicary C; Guler HP
    JAMA; 2003 Apr; 289(14):1826-32. PubMed ID: 12684362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.
    Grube B; Chong PW; Alt F; Uebelhack R
    J Obes; 2015; 2015():953138. PubMed ID: 26435849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.